Study of Congenital Orofacial Clefts by Implementing Optical Genome Mapping

Recruiting N/A Interventional Study
Orofacial Clefts Next Generation Sequencing (NGS) Optical Genome Mapping
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
26 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Orofacial clefts, the most common congenital craniofacial malformations, have a complex etiology involving an interaction between genetic and environmental factors. Chromosomal abnormalities, including structural variations, represent a major cause of human pathology. Recently, technological developments and the introduction of next-generation sequencing (NGS) technologies have revolutionized the…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Individuals with syndromic, complex or familial oral-facial clefts * With no established genetic diagnosis * Followed up at the Amiens-Picardie University Hospital Exclusion Criteria: * genetic diagnosis of oral-facial cleft * No health insurance affiliation * Patient under …
Contacts

Bénédicte DEMEER, MD

33+322087581

Demeer.Benedicte@chu-amiens.fr

CONTACT